Cost/benefit relationship in 46 cases of myelodysplastic syndrome (RAEB and RAEB-T): A quality assurance analysis in clinical haematology

G. Baldi, M. D'Inca, L. Saltini, P. Zanoni, A. Ghirarduzzi, F. Gobbi

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)291-296
Number of pages6
Issue number5
Publication statusPublished - 1993


  • myelodysplastic syndromes
  • quality assurance analysis
  • therapy costs

ASJC Scopus subject areas

  • Hematology

Cite this